Please login to the form below
Artios Pharma
This page shows the latest Artios Pharma news and features for those working in and with pharma, biotech and healthcare.
UK biotech Artios Pharma appoints new medical director
Joins from senior role at Lilly. UK-based Artios Pharma has unveiled Dr Ian Smith, former Lilly and AstraZeneca clinical development leader, as its new chief medical officer. ... The Artios pipeline offers one of the most exciting approaches to cancer
Latest news
-
DNA damage specialists Artios Pharma raises $84m
Team behind development of Lynparza focus on next-gen DDR inhibitors. Cambridge, UK-based Artios Pharma has raised $84 million (£65 million) in a series B financing. ... Artios’ existing shareholders Arix Bioscience, SV Health Investors, M Ventures,
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Artios Pharma appoints science strategy VP
Francis Crick Institute lead Dr Simon Boulton joins management team. Cambridge, UK-based Artios Pharma has appointed Dr Simon Boulton as vice president of science strategy. ... He brings over 20 years of expertise in DNA repair and the treatment of
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- How COVID-19 is accelerating the threat of antimicrobial resistance
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Keytruda doubles five-year survival rate in NSCLC
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
OPEN Health
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
